** Stu's Views & M.S. News **: Clinical Trials in Multiple Sclerosis 2010

ABOUT this BLOG and How to use it

WELCOME to Stu's Views & MS News. A product of MS Views and News, a Not-for-Profit [501c3] organization. Founded in 2008, we provide educational Multiple Sclerosis information via live seminars and via the internet.

Key-Notes: Our live seminars average approx 60 people per educational program. Our blog is visited over 2900 times per week and our website is visited by thousands each month.

Register at our website to receive our globally transmitted Multiple Sclerosis e-newsletter, currently being received in (90) Countries.

On this blog see our Directory, Archives, recent Blog Posts & so much more. Use the Blog Search box (enter a keyword). See our Facebook information AND Links to other MS Organizations & bloggers. Scroll through entire page, to find information that could EMPOWER You. At the Bottom of this page, see informational videos and some for fun.

Disclaimer: "Stu's Views & MS News" / 'MS Views and News' does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Monday, June 7, 2010

Clinical Trials in Multiple Sclerosis 2010

We’re pleased to present our annual listing of Clinical Trials in MS 2010 (PDF), featuring ongoing MS trials, as well as those that are being planned or that have been recently completed. This year’s list of 129 studies indicates an exciting time in MS research, with therapies progressing through the drug development pipeline. Here are some of the highlights:

· 58 studies of oral drugs for treating MS or its symptoms, up from 37 in 2008
· Novel agents being tested for neuroprotective capabilities, including two trials of green tea extracts and one of the pain reliever fluripitine maleate; and a study of the antioxidant idebenone in people with primary-progressive MS.

This list is prepared from materials provided by investigators, published literature and public presentations. While we strive for accuracy and completeness, there are trials that were not included because we were unable to gather sufficient information about them, and there may be inaccuracies due to changes in protocol.

Clinical Trial Participation Resources on Our Web Site

Because recruitment information changes frequently, we do not indicate which studies on this list are enrolling patients. For that information, go to the Clinical Trials section of our Web site, where there is a database of recruiting studies that is searchable by state, type of MS, or keyword, and MS Trial Alerts about specific studies. This section also includes a brochure and an online course to guide people through the process of deciding whether to enroll in a clinical trial.

SOURCE: National MS Society

share with others by clicking on of the links shown below

*

Share |

****************************************************************

"Providing You with 'MS Views and News', is what we do"